Published in Microbes Infect on June 06, 2006
IFN-γ plays a unique role in protection against low virulent Trypanosoma cruzi strain. PLoS Negl Trop Dis (2012) 0.94
Trypanosoma cruzi: role of δ-amastin on extracellular amastigote cell invasion and differentiation. PLoS One (2012) 0.89
Trypanosoma cruzi extracellular amastigotes and host cell signaling: more pieces to the puzzle. Front Immunol (2012) 0.86
Molecular Characterization of a Novel Family of Trypanosoma cruzi Surface Membrane Proteins (TcSMP) Involved in Mammalian Host Cell Invasion. PLoS Negl Trop Dis (2015) 0.83
Unique behavior of Trypanosoma cruzi mevalonate kinase: A conserved glycosomal enzyme involved in host cell invasion and signaling. Sci Rep (2016) 0.81
Extracellular amastigotes of Trypanosoma cruzi are potent inducers of phagocytosis in mammalian cells. Cell Microbiol (2013) 0.80
Mechanisms of Infectivity and Evasion Derived from Microvesicles Cargo Produced by Trypanosoma cruzi. Front Cell Infect Microbiol (2016) 0.75
Oral Outbreak of Chagas Disease in Santa Catarina, Brazil: Experimental Evaluation of a Patient's Strain. PLoS One (2015) 0.75
Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression. Parasitol Res (2011) 0.75
Chagas disease. Lancet (2010) 10.25
Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med (2006) 6.00
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med (2015) 5.31
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
American trypanosomiasis (Chagas disease). Infect Dis Clin North Am (2012) 2.04
Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation (2007) 1.99
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J (2008) 1.99
An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion (2003) 1.59
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz (2009) 1.54
Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz (2009) 1.48
Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol (2005) 1.41
Should tissue Doppler echocardiography be used to improve prediction of mortality risk in patients with Chagas cardiomyopathy? Int J Cardiol (2011) 1.38
Cardiac involvement with parasitic infections. Clin Microbiol Rev (2010) 1.32
Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol (2004) 1.16
Another disappointing result with implantable cardioverter-defibrillator therapy in patients with Chagas disease. Europace (2013) 1.08
The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models. DNA Res (2013) 1.06
[Guidelines for the evaluation and treatment of patients with cardiac arrhythmias]. Arq Bras Cardiol (2003) 1.06
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz (2009) 1.05
Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. PLoS Negl Trop Dis (2012) 1.03
Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland. J Clin Microbiol (2010) 1.01
Posaconazole versus benznidazole for chronic Chagas' disease. N Engl J Med (2014) 0.98
The localized adherence pattern of an atypical enteropathogenic Escherichia coli is mediated by intimin omicron and unexpectedly promotes HeLa cell invasion. Cell Microbiol (2007) 0.98
Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Int J Parasitol (2007) 0.98
Infection by Trypanosoma cruzi metacyclic forms deficient in gp82 but expressing a related surface molecule, gp30. Infect Immun (2003) 0.98
Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation (2012) 0.98
Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected mice. Microbes Infect (2005) 0.98
Letter by Rassi and Rassi regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors". Circulation (2013) 0.97
Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells. Int Immunopharmacol (2007) 0.96
PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J Clin Microbiol (2003) 0.96
[A retrospective search for maternal transmission of Chagas infection from patients in the chronic phase]. Rev Soc Bras Med Trop (2005) 0.94
ARF6, PI3-kinase and host cell actin cytoskeleton in Toxoplasma gondii cell invasion. Biochem Biophys Res Commun (2008) 0.94
Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection. Parasitol Res (2006) 0.93
Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical forms. Am J Trop Med Hyg (2012) 0.92
Update on Chagas heart disease on the first centenary of its discovery. Rev Esp Cardiol (2009) 0.92
The flagellar attachment zone of Trypanosoma cruzi epimastigote forms. J Struct Biol (2005) 0.90
Morphological characterization of mouse B-1 cells. Immunobiology (2003) 0.90
Exercise-induced hippocampal anti-inflammatory response in aged rats. J Neuroinflammation (2013) 0.89
Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory. J Immunol Methods (2006) 0.89
Early exercise promotes positive hippocampal plasticity and improves spatial memory in the adult life of rats. Hippocampus (2010) 0.88
Cytotoxic and genotoxic effects of megazol, an anti-Chagas' disease drug, assessed by different short-term tests. Biochem Pharmacol (2002) 0.88
Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia (2010) 0.88
Highly effective serodiagnosis for Chagas' disease. Clin Vaccine Immunol (2010) 0.87
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease. Am J Cardiol (2012) 0.87
Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol (2005) 0.87
Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0-5 years in Brazil. Acta Trop (2010) 0.86
A surface 75-kDa protein with acid phosphatase activity recognized by monoclonal antibodies that inhibit Paracoccidioides brasiliensis growth. Microbes Infect (2007) 0.86
Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions. Cell Microbiol (2014) 0.85
The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum--new tools for designing specific inhibitors. Biochem Biophys Res Commun (2009) 0.85
Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. Am J Trop Med Hyg (2007) 0.84
Protein tyrosine kinases in Schistosoma mansoni. Mem Inst Oswaldo Cruz (2006) 0.84
Interclonal variations in the molecular karyotype of Trypanosoma cruzi: chromosome rearrangements in a single cell-derived clone of the G strain. PLoS One (2013) 0.83
Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease. Clin Diagn Lab Immunol (2002) 0.82
Characterization of the presence and distribution of Foxp3(+) cells in chagasic patients with and without megacolon. Hum Immunol (2008) 0.82
Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease. J Immunol Methods (2011) 0.82
[Congenital transmission of Trypanosoma cruzi in Brazil: estimation of prevalence based on preliminary data of national serological surveys in children under 5 years old and other sources]. Rev Soc Bras Med Trop (2005) 0.82
Human autoantibodies specific for neurotrophin receptors TrkA, TrkB, and TrkC protect against lethal Trypanosoma cruzi infection in mice. Am J Pathol (2008) 0.82
B-1 cells are pivotal for in vivo inflammatory giant cell formation. Int J Exp Pathol (2005) 0.81
[Correlation among the positivity of the artificial xenodiagnosis and the amount of blood and triatomines used in the exam, in chronic chagasic patients]. Rev Soc Bras Med Trop (2002) 0.81
Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis. Int J Antimicrob Agents (2010) 0.81
Glial fibrillary acidic protein and S-100 colocalization in the enteroglial cells in dilated and nondilated portions of colon from chagasic patients. Hum Pathol (2008) 0.81
Intracellular localization of myeloperoxidase in murine peritoneal B-lymphocytes and macrophages. Cell Immunol (2013) 0.79
Enteroglial cells act as antigen-presenting cells in chagasic megacolon. Hum Pathol (2011) 0.79
Unique behavior of Trypanosoma dionisii interacting with mammalian cells: invasion, intracellular growth, and nuclear localization. Acta Trop (2009) 0.78
Trypanosoma cruzi trypomastigotes induce cytoskeleton modifications during HeLa cell invasion. Mem Inst Oswaldo Cruz (2011) 0.78
Trypanosoma cruzi cell invasion and traffic: influence of Coxiella burnetii and pH in a comparative study between distinct infective forms. Microb Pathog (2007) 0.78
Recruitment of galectin-3 during cell invasion and intracellular trafficking of Trypanosoma cruzi extracellular amastigotes. Glycobiology (2013) 0.77
A cell surface 230 kDa protein from murine melanoma involved with tumor malignancy. Cancer Lett (2008) 0.77
Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial. J Cardiovasc Electrophysiol (2007) 0.77
Substance P and NK1 receptor expression in the enteric nervous system is related to the development of chagasic megacolon. Trans R Soc Trop Med Hyg (2008) 0.77
Lysosomal exocytosis: an important event during invasion of lamp deficient cells by extracellular amastigotes of Trypanosoma cruzi. Biochem Biophys Res Commun (2009) 0.77
A century of research: what have we learned about the interaction of Trypanosoma cruzi with host cells? Mem Inst Oswaldo Cruz (2009) 0.77
Kallikrein 1 is overexpressed by astrocytes in the hippocampus of patients with refractory temporal lobe epilepsy, associated with hippocampal sclerosis. Neurochem Int (2011) 0.77
Regenerative process evaluation of neuronal subclasses in chagasic patients with megacolon. Hum Immunol (2012) 0.77
Phosphatidylinositol-and related-kinases: a genome-wide survey of classes and subtypes in the Schistosoma mansoni genome for designing subtype-specific inhibitors. Biochem Biophys Res Commun (2009) 0.77
[Optimization of the medical treatment in coronary artery disease: a task for the subspecialist?]. Arq Bras Cardiol (2004) 0.77
A nature-inspired betalainic probe for live-cell imaging of Plasmodium-infected erythrocytes. PLoS One (2013) 0.77
Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern. Rheumatology (Oxford) (2009) 0.77
A Latin American man with palpitations, dizziness, episodes of nonsustained ventricular tachycardia, and an apical aneurysm. PLoS Negl Trop Dis (2011) 0.76
Expression of caspase-3 in enteric cells is related to development of chagasic megacolon. Hum Pathol (2009) 0.76
Decreased expression of IK channels in neurons from enteric nervous system is associated with the development of chagasic megacolon. Hum Pathol (2008) 0.76
Letter by Rassi et al regarding article, "Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial". Circ Heart Fail (2010) 0.75
Predicting prognosis in patients with Chagas disease: why are the results of various studies so different? Int J Cardiol (2009) 0.75
Case 2-2010: a man with abdominal and flank pain. N Engl J Med (2010) 0.75
The art of risk stratification in Chagas' disease. J Cardiovasc Electrophysiol (2008) 0.75
Prognostic utility of coronary computed tomography angiography: are we looking at the correct outcomes and making appropriate comparisons? JACC Cardiovasc Imaging (2009) 0.75
[Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease]. Rev Soc Bras Med Trop (2006) 0.75
Preventing type 2 diabetes mellitus with angiotensin blockade: is it clinically relevant? J Am Coll Cardiol (2006) 0.75